Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 41 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

41 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Feb. 21, 2024 LH S 500 $215.49 $107,745 3,401 Direct -12.82% Disposed 43.0% (price as of 2026-10-05)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Sept. 5, 2026 BIO Restricted Stock Units Bio-Rad A Common Stock (1,712) · · 1,712 Disposed
Sept. 4, 2026 BIO Restricted Stock Units Bio-Rad A Common Stock (6,326) · · 6,326 Acquired
Oct. 24, 2025 BIO Restricted Stock Units Bio-Rad A Common Stock (1,869) · · 1,869 Disposed
Sept. 5, 2025 BIO Restricted Stock Units Bio-Rad A Common Stock (6,850) · · 6,850 Acquired
March 3, 2025 BIO Non-Qualified Stock Option (right to buy) Bio-Rad A Common Stock (4,863) $256.45 March 3, 2035 4,863 Acquired
Oct. 24, 2024 BIO Restricted Stock Units Bio-Rad A Common Stock (7,478) · · 7,478 Acquired
March 27, 2024 LH Restricted Stock Unit Common Stock (3,012) · · 3,012 Disposed
Feb. 11, 2024 LH Restricted Stock Unit Common Stock (201) · · 201 Disposed
Feb. 7, 2024 LH Restricted Stock Unit Common Stock (138) · · 138 Disposed
Feb. 7, 2024 LH Restricted Stock Unit Common Stock (224) · · 224 Disposed
Feb. 6, 2024 LH Non-qualified Stock Options [F5] Common Stock (3,000) $222.28 Feb. 5, 2034 3,000 Acquired
Feb. 6, 2024 LH Restricted Stock Unit Common Stock (980) · · 980 Acquired
Feb. 2, 2024 LH Restricted Stock Unit Common Stock (246) · · 246 Disposed
Dec. 15, 2023 LH Restricted Stock Unit Common Stock (64) · · 64 Disposed
June 30, 2023 LH Restricted Stock Unit Common Stock (3,036) · · 3,036 Acquired
May 5, 2023 LH Restricted Stock Unit Common Stock (370) · · 370 Acquired
May 5, 2023 LH Non-qualified Stock Options [F1] Common Stock (1,200) $223.86 May 4, 2033 1,200 Acquired
Feb. 9, 2016 RVTY NQ Stock Option (right to buy) Common Stock (31,917) $42.47 Feb. 9, 2023 31,917 Acquired
Feb. 3, 2015 RVTY NQ Stock Option (right to buy) Common Stock (26,667) $46.83 Feb. 3, 2022 26,667 Acquired
Feb. 4, 2014 RVTY NQ Stock Option (right to buy) Common Stock (22,542) $43.01 Feb. 4, 2021 22,542 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 6 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Sept. 17, 2024 BIO No securities beneficially owned 0 Direct
May 8, 2023 LH Common Stock 3,290 Direct
May 8, 2023 LH Restricted Stock Unit→ Common Stock (220) 220 Direct
May 8, 2023 LH Restricted Stock Unit→ Common Stock (114) 114 Direct
May 8, 2023 LH Restricted Stock Unit→ Common Stock (600) 600 Direct
May 8, 2023 LH Restricted Stock Unit→ Common Stock (360) 360 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

BIO

COO
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2025 $673,208 · · · $476,702 · $23,044 $3,680,772
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2016 $352,692 · · · · · $777,814 $1,733,139
2015 $427,692 · · · $277,816 · $16,740 $1,308,933
2014 $400,000 · · · $294,600 · $18,350 $1,246,246

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.